Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen Alexion Pharmaceuticals Inc stake
total: 670
Viking Global Investors ALXN trades
- Total transactions:
- 10
- New positions:
- 2
- Sold out:
- 2
- Added:
- 2
- Reduced:
- 4
- Held since:
- 2015 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2015 Q3
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any Alexion Pharmaceuticals Inc (ALXN) shares. Viking Global Investors has held ALXN since at least 2013 Q2 with about 5.54M shares in our earliest available record. Ole Andreas Halvorsen later completely sold out the position and invested in Alexion Pharmaceuticals Inc again in 2015 Q2. Since at least 2013 Q2, Viking Global Investors has made 9 more transactions.
When did Ole Andreas Halvorsen sell Alexion Pharmaceuticals Inc (ALXN)?
Ole Andreas Halvorsen sold off the entire Alexion Pharmaceuticals Inc (ALXN) position in 2015 Q3.
Estimated cost basis*
- Weighted AVG buy price:
- $180.77
- Weighted AVG sell price:
- $180.77
Ole Andreas Halvorsen's historical trades in Alexion Pharmaceuticals Inc
10 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2015 Q3
|
0.00%
|
$180.77
|
-100% (-201,756)
|
|||
|
2015 Q2
|
0.14%
|
$180.77
|
new
|
|||
|
2015 Q1
|
0.00%
|
$185.03
|
-100% (-390,271)
|
|||
|
2014 Q4
|
0.33%
|
$185.03
|
-82.25% (-1,808,180)
|
|||
|
2014 Q3
|
1.46%
|
$165.82
|
+9.59% (+192,359)
|
|||
|
2014 Q2
|
1.37%
|
$156.25
|
+9.23% (+169,434)
|
|||
|
2014 Q1
|
1.17%
|
$152.13
|
-36.16% (-1,040,350)
|
|||
|
2013 Q4
|
1.78%
|
$132.88
|
-16.72% (-577,632)
|
|||
|
2013 Q3
|
2.22%
|
$116.16
|
-37.70% (-2,090,309)
|
|||
|
2013 Q2
|
2.84%
|
$92.24
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.